溃疡性结肠炎自然疗法
- 肠道益生菌 (Probiotics): 肠道益生菌可能有助于治疗溃疡性结肠炎。一项共有116位溃疡性结肠炎患者参与的双盲试验发现,与小剂量的药物美沙拉秦 (溃疡性结肠炎的常规用药) 治疗相比,服用肠道益生菌在控制症状和缓和病情方面有相类似的效果。其他的一些临床试验也证实了肠道益生菌对溃疡性结肠炎的治疗效果。进行过部分或全部结肠切除术的溃疡性结肠炎患者,常会发生结肠袋炎 (即残留的肠段发生炎症),肠道益生菌对他们也有一定的疗效。两项双盲试验发现,肠道益生菌可以降低结肠袋炎的发病率和减少其复发。在这两项试验中使用的益生菌包括四种乳酸杆菌、三种双岐杆菌和一种唾液链球菌。另外还有研究提示,肠道益生菌可以缓解炎症性肠病患者经常出现的关节疼痛。
- 芦荟 (Aloe): 在一项为期4周的双盲试验中,44名正处于严重溃疡性结肠炎发病期的患者被分为两组,分别服用芦荟凝胶或者安慰剂 (作为对照用) 进行治疗,结果显示,与对照组 (即口服安慰剂组) 相比,芦荟对改善症状更为有效。
- 磷酸卵磷脂 (Phosphadylcholine): 作为对严重溃疡性结肠炎的辅助性治疗,磷酸卵磷脂越来越受到人们的关注,这可能是因为这种成分在溃疡性结肠炎患者的结肠粘膜中含量不足,需要通过口服磷酸卵磷脂来弥补。在一项历时12周的小规模双盲试验中,60名对皮质类固醇药物治疗效果不佳的溃疡性结肠炎患者被随机分为两组,分别给予安慰剂 (作为对照用) 或者磷酸卵磷脂 (每天 2g) 的治疗。结果发现服用磷酸卵磷脂的患者中有一半人其症状得到了明显的改善,而且其中 80% 的患者可以彻底停用皮质类固醇药物而没有发生病情恶化。
- 姜黄素 (Curcumin): 从姜黄中提取的姜黄素被认为有助于缓解溃疡性结肠炎的症状。一项为期6个月的双盲试验中,89位处于缓解期的溃疡性结肠炎患者被随机分为两组,在常规治疗的基础上分别给予安慰剂或姜黄素 (一天两次,每次 1g) 的治疗。结果表明,与作为对照用的安慰剂组相比,服用姜黄素的患者其溃疡性结肠的复发率明显降低。
参考文献
- Striola GC, Restrainer C, Lecis PE, et al. Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scand J Gastroenterol. 1998;33:644-649.
- Mortensen PB, Abildgaard K, Fallingborg J. Serum selenium concentration in patients with ulcerative colitis. Dan Med Bull. 1989;36:568-570.
- Dronfield MW, Malone JD, Langman MJ. Zinc in ulcerative colitis: a therapeutic trial and report on plasma levels. Gut. 1977;18:33-36.
- Elsborg L, Larsen L. Folate deficiency in chronic inflammatory bowel disease. Scand J Gastroenterol. 1979;14:1019-1024.
- Krasinski SD, Russell RM, Furie BC, et al. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders. Am J Clin Nutr. 1985;41:639-643.
- Bischoff SC, Herrmann A, Goke M, et al. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol. 1997;92:1157-1163.
- Dibble JB, Sheridan P, Losowsky MS. A survey of vitamin D deficiency in gastrointestinal and liver disorders. Q J Med. 1984;53:119-134.
- Mulder TP, van der Sluys Veer A, Verspaget HW, et al. Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease. J Gastroenterol Hepatol. 1994;9:472-477.
- Ainley CC, Cason J, Carlsson LK, et al. Zinc status in inflammatory bowel disease. Clin Sci (Colch). 1988;75:277-283.
- Halsted CH, Ghandi G, Tamura T. Sulfasalazine inhibits the absorption of folates in ulcerative colitis. N Engl J Med. 1981;305:1513-1517.
- Aslan A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol. 1992;87:432-437.
- Almallah YZ, El-Tahir A, Heys SD, et al. Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest. 2000;30:58-65.
- Stenson WF, Cort D, Rodgers J, et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med. 1992;116:609-614.
- Hawthorne AB, Daneshmend TK, Hawkey CJ, et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12-month randomised controlled trial. Gut. 1992;33:922-928.
- Greenfield SM, Green AT, Teare JP, et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther. 1993;7:159-166.
- Greenfield SM, Green AT, Teare JP, et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther. 1993;7:159-166.
- Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. 1999;354:635-639.
- Faubion WA, Sandborn WJ. Probiotic therapy with E. coli for ulcerative colitis: take the good with the bad. Gastroenterology. 2000;118:630-631.
- Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:305-309.
- Candy S, Borok G, Wright JP, et al. The value of an elimination diet in the management of patients with ulcerative colitis. S Afr Med J. 1995;85:1176-1179.
- Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003;124:1202-1209.
- Langmead L, Feakins RM, Goldthorpe S, et al. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther. 2004;19:739-748.
- Kato K, Mizuno S, Umesaki Y, et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther. 2004;20:1133-1141.
- Karimi O, Pena AS, van Bodegraven AA, et al. Probiotics (VSL#3) in arthralgia in patients with ulcerative colitis and Crohn's disease: A pilot study. Drugs Today (Barc). 2005;41:453-459.
- Hanai H, Iida T, Takeuchi K, et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006 Nov 10. [Epub ahead of print]
- Mallon P, McKay D, Kirk S, et al. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2007 Oct 17;CD005573.
最后修改日期 : 2018-1-4
© 2024 以上资料由医博士(DrMed)编辑。版权归医博士(DrMed)所有,未经授权,不得转载!